🇺🇸 FDA
Patent

US 6331630

Dimeric arylisoquinoline alkaloids and derivatives thereof

expired A61KA61K31/47A61P

Quick answer

US patent 6331630 (Dimeric arylisoquinoline alkaloids and derivatives thereof) held by The United States of America, as represented by the Department of Health and Human Services expires Mon Dec 13 2021 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
The United States of America, as represented by the Department of Health and Human Services
Grant date
Tue Dec 18 2001 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 13 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
11
CPC classes
A61K, A61K31/47, A61P, A61P33/06